Andrew Ritter

Andrew Ritter is an experienced executive with a strong background in healthcare and biotechnology. Currently serving as the Chief Executive Officer of Cairns Health since September 2023, Andrew is leading the development of Luna, a digital care companion platform for senior living and home care. Previously held positions include Chief Executive Officer of Docbot, where Andrew advanced AI technology for diagnosing gastrointestinal diseases, and President and Chief Executive Officer of Ritter Pharmaceuticals, a company known for developing the first potential FDA-approved treatment for lactose intolerance. Additionally, Andrew served on the board of Myosin Therapeutics, focusing on innovative therapies targeting cellular motor proteins. Andrew's educational background includes an MBA in Finance from The Wharton School and a BA in Political Science from the University of Southern California.